Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  10/18/2011
 
Trade Name:  Ixempra Kit
 
Generic or Proper Name (*):  ixabepilone
 
Indications Studied:  Advanced or refractory solid tumors
 
Therapeutic Category:  Antineoplastic
 
Ages Studied:  3-18 years
 
Study #:  2
 
Study Type:  Efficacy/Safety
 
Study Design:  Open Label
 
No Patients:  47
 
BPCA(B), PREA(P):  B
 
Unknown:  0
 
-
-